MissionIR today announces that its interview with Shawn Singh, the Chief Executive Officer of VistaGen Therapeutics, is now available online. The complete interview can be heard at http://www.vsta.missionir.com/vsta-12-11.mp3.
Mr. Singh provided a brief overview of the company, its drug rescue business model, collaborations in place, milestones achieved this year as well as plans for 2012, which include listing on a higher exchange. He also discussed the background of the company’s executive management team and advisory board.
“Since our inception about thirteen years ago, we have obtained and carefully employed more than $42 million of capital,” Mr. Singh stated in the interview. “We have been tremendously resourceful in very challenging times, developing a portfolio of technologies with incredible therapeutic commercial potential across a wide range of applications. In 2012 and beyond, we look to achieve a number of milestones that will advance our company to new heights.”
About MissionIR:
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
